This content is from: Patents

China’s Supreme People’s Court consults on evidence admissibility in patent validity proceedings

We spoke to lawyers in China to ask what the guidelines mean for patent litigation, especially in chemical/pharmaceutical cases

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial